Study of HS235 for Assessing the Pharmacokinetics, Safety, and Pharmacodynamics in Overweight/Obese Healthy Subjects

Clinical trial NCT06714825 · COMPLETED

Trial details

NCT number: NCT06714825
Sponsor: 35Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Overweight and Obesity

Start date: 2024-11-28
Primary completion: 2025-12-02
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.